Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-007234
Filing Date
2025-11-24
Accepted
2025-11-24 16:04:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2849
  Complete submission text file 0001959173-25-007234.txt   4650
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Subject) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-32639 | Film No.: 251512866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LFB BIOTECHNOLOGIES, S.A.S. 3, AVENUE DES TROPIQUES LES ULIS COURTABOEUF France
Business Address
Echelard Yann (Reporting) CIK: 0001561958 (see all company filings)

Type: 144